|
SUGT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.86739999971952E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16320000000692E-05 |
| Normal-vs-Stage2 |
1.422670E-04 |
| Normal-vs-Stage3 |
8.72690000042198E-07 |
| Normal-vs-Stage4 |
1.67529999994809E-06 |
| Stage1-vs-Stage2 |
1.567650E-01 |
| Stage1-vs-Stage3 |
9.499500E-02 |
| Stage1-vs-Stage4 |
7.632300E-02 |
| Stage2-vs-Stage3 |
8.585200E-01 |
| Stage2-vs-Stage4 |
9.863400E-01 |
| Stage3-vs-Stage4 |
8.260800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.58810000003984E-07 |
| Normal-vs-AfricanAmerican |
2.928100E-02 |
| Normal-vs-Asian |
3.379800E-04 |
| Caucasian-vs-AfricanAmerican |
7.193200E-01 |
| Caucasian-vs-Asian |
8.763200E-01 |
| AfricanAmerican-vs-Asian |
8.240200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.14420000002702E-06 |
| Normal-vs-Female |
1.2339999999611E-06 |
| Male-vs-Female |
6.022800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.643600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.76250000039069E-07 |
| Normal-vs-Age(61-80Yrs) |
5.1725000005387E-07 |
| Normal-vs-Age(81-100Yrs) |
7.243300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.803800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.402800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.116100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.879000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.940200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.390200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.343400E-01 |
| Classical-VS-Follicular |
7.832000E-01 |
| Classical-VS-Other |
5.242000E-01 |
| Classical-VS-Normal |
1.6338499999935E-05 |
| Tall-VS-Follicular |
4.068000E-01 |
| Tall-VS-Other |
3.295600E-01 |
| Tall-VS-Normal |
2.46699999999489E-05 |
| Follicular-VS-Other |
4.106200E-01 |
| Follicular-VS-Normal |
1.775590E-04 |
| Other-VS-Normal |
6.170200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.04759999955506E-07 |
| Normal-vs-N1 |
1.47600000000025E-06 |
| N0-vs-N1 |
5.659800E-01 |
|
|
